Page 100 - 30917_ASHG_Complete

This is a SEO version of 30917_ASHG_Complete. Click here to view full version

« Previous Page Table of Contents Next Page »
Tuesday, October 11
5:00
PM
–6:30
PM
SESSION 2 – Panel Discussion: Whole Genome
Sequencing: To Do It or Not to Do It?
Room 210, Level 2, Convention Center
Moderator:
Kevin Davies, Bio-IT World, USA
Panelists:
James Lupski
Baylor Col. of Med., USA
Seong-Jin Kim
CHA Univ., South Korea
James Watson
Cold Spring Harbor Lab., USA
Marjolein Kriek
Leiden Univ., Netherlands
As full-genome sequencing becomes more common, it
is imperative that the human genetics community
understands the personal implications of genome
sequencing as well as the science. In this exciting
opening session, four well-known geneticists whose
genomes have been sequenced will be panelists in a
discussion moderated by the author of “The $1000
Genome”. The scientists will be asked why they
decided to have their genomes sequenced and how it
has affected their lives, professionally and personally.
The discussion will cover both basic information and
provocative questions, and the panel should ignite
lively discussions that persist throughout the
Congress.
Cameras and all other recording devices are
strictly prohibited
in all session rooms. Thank you for your cooperation
Wednesday, October 12
8:00
AM
–10:00
AM
SESSION 3 – Plenary Session on Epigenetics
Room 210, Level 2, Convention Center
Moderator:
Yoichi Matsubara, Tohoku Univ. Sch. of
Med., Japan
Mendelian expression of disease has been
documented for more than a century, but the
recognition of complex etiology of phenotypes
resulting from developmental, epigenetic, and
mitochondrial gene expression is much more recent
this session, the speakers will explore multiple
phenomena affecting the interplay between genes a
complex disease, including the role of energy syste
directed by mtDNA and nDNA. In addition, the
stochastic establishment of epigenetic modifications
including DNA methylation and chromatin remodelin
will be presented. Examples of these processes in
normal and abnormal phenotypic models will
demonstrate new understandings of the challenges
clarifying how gene expression interacts with
environmental factors to make genotype/phenotype
correlations more complex.
8:00
Introduction.
Y. Matsubara. Tohoku Univ. Sch.
Med., Japan.
8:05
Energyomics-energenomics:
mitochondrial etiology of commo
diseases.
D. C. Wallace. Children’s
Hosp. of Philadelphia, USA.
8:45
Epigenetics and determining
phenotype.
E. Whitelaw. Queenslan
Inst. of Med. Res., Australia.
1
/9:25
Identification of a mosaic activating mutati
as the molecular basis of Proteus syndrome usin
massively parallel sequencing of affected tissues
L. G. Biesecker, M. J. Lindhurst, J. C. Sapp, J. K. T
J. J. Johnston, K. Peters, J. Turner, D. Bick, L.
Blakemore, K. Brockman, P. Calder, M. Deardorff, D
B. Everman, R. M. Greenstein, B. M. Kato, K. M.
Keppler-Noreuil, R. T. Miyamoto, K. Newman, S.
Rothenberg, D. J. Schwartzentruber, V. Singhal, J.
Upton, S. Wientroub, E. H. Zackai, P. G. Robey, P. L
Schwartzberg, T. N. Darling, L. L. Tosi, J. C. Mullikin
2
/9:40
Germline deletion of the miR-17~92 cluste
causes developmental defects in human.
J. Amiel
E. Yao, P. Callier, L. Faivre, V. Drouin, S. Cariou, A.
Haeringen, D. Genevieve, A. Goldenberg, M. Oufade
S. Manouvrier, A. Munnich, J. Alves Vidigal, S.
Lyonnet, A. Henrion-Caude, A. Ventura, L. de Pontu
9:55
Questions and answers.
Y. Matsubara. Tohok
Univ. Sch. of Med., Japan.